Objectives: The objective was to compare the use of low-dose liraglutide ... with 1 or more prescription orders or claims for LD-L or another GLP-1 RA between 2014 and 2016 (Table 1).

Results of the investigators’ analyses indicated GLP-1 receptor agonist use was associated with significant reductions in body weight (90.5kg to 85.4kg, P <.001), HbA1c (7.7% to 7.3%, P=.007 ...

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA ... Last Ozempic dose at seven days prior to surgery was identified as an independent risk factor for conversion to intubation in ...

(HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA ... Ozempic dose at seven days prior to surgery was identified as an independent risk factor for conversion ...